Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shanshan Dai

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
Toxicology and Applied Pharmacology|January 12, 2026
GSDMD inhibitor GI-Y1 alleviates doxorubicin-induced cardiotoxicity via the inhibition of mitochondrial dysfunctionYucong Zhang, Ruihan Zheng, Minne Xie, et al.
Hypertension (Dallas, Tex. : 1979)|September 6, 2022
GSDMD (Gasdermin D) Mediates Pathological Cardiac Hypertrophy and Generates a Feed-Forward Amplification Cascade via Mitochondria-STING (Stimulator of Interferon Genes) AxisJibo Han, Shanshan Dai, Lingfeng Zhong, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 4, 2026
Cardiomyocyte-Derived USP20 Attenuates Diabetic Cardiomyopathy by Facilitating the Degradation of STING and Mitigating STING-Mediated InflammationYixin Zhou, Miaomiao Ying, Baozhen Qi, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 7, 2025
Cardiomyocyte-Enriched USP20 Ameliorates Pathological Cardiac Hypertrophy by Targeting STAT3 DeubiquitinationLingfeng Zhong, Shanshan Dai, Fan Yu, et al.
Theranostics|June 29, 2026
Cardiomyocyte-derived USP20 mitigates myocardial ischemia/reperfusion injury through deubiquitinating GRP78Zhenfeng Cheng, Lingfeng Zhong, Miaomiao Ying, et al.
Frontiers in Immunology|December 24, 2025
Novel nanobody-161 binds tumor necrosis factor receptor 2 (TNFR2) to exert an anti-tumor effect but does not block TNFα-bindingLiang Huang, Chao Kong, Yuhao Hu, et al.
Nature|May 14, 2025
Genome diversity and signatures of natural selection in mainland Southeast AsiaYaoxi He, Xiaoming Zhang, Min-Sheng Peng, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
Toxicology and Applied Pharmacology|January 12, 2026
GSDMD inhibitor GI-Y1 alleviates doxorubicin-induced cardiotoxicity via the inhibition of mitochondrial dysfunctionYucong Zhang, Ruihan Zheng, Minne Xie, et al.
Hypertension (Dallas, Tex. : 1979)|September 6, 2022
GSDMD (Gasdermin D) Mediates Pathological Cardiac Hypertrophy and Generates a Feed-Forward Amplification Cascade via Mitochondria-STING (Stimulator of Interferon Genes) AxisJibo Han, Shanshan Dai, Lingfeng Zhong, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 4, 2026
Cardiomyocyte-Derived USP20 Attenuates Diabetic Cardiomyopathy by Facilitating the Degradation of STING and Mitigating STING-Mediated InflammationYixin Zhou, Miaomiao Ying, Baozhen Qi, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 7, 2025
Cardiomyocyte-Enriched USP20 Ameliorates Pathological Cardiac Hypertrophy by Targeting STAT3 DeubiquitinationLingfeng Zhong, Shanshan Dai, Fan Yu, et al.
Theranostics|June 29, 2026
Cardiomyocyte-derived USP20 mitigates myocardial ischemia/reperfusion injury through deubiquitinating GRP78Zhenfeng Cheng, Lingfeng Zhong, Miaomiao Ying, et al.
Frontiers in Immunology|December 24, 2025
Novel nanobody-161 binds tumor necrosis factor receptor 2 (TNFR2) to exert an anti-tumor effect but does not block TNFα-bindingLiang Huang, Chao Kong, Yuhao Hu, et al.
Nature|May 14, 2025
Genome diversity and signatures of natural selection in mainland Southeast AsiaYaoxi He, Xiaoming Zhang, Min-Sheng Peng, et al.
Pageof 8